Lucid Diagnostics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +32.8% | -3.7% | -2.5% | +20.1% | +2.1% | -30.8% | +40.5% | +4.1% | +24.2% | -16.5% | +17.4% | – | |
| – | -10.8% | +13.7% | -2.5% | +4.3% | +27.4% | -27.7% | +15.1% | -4.9% | +9.6% | -0.7% | -21.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +18.8% | -21.7% | -8.6% | +21.4% | -12.8% | -1.7% | -12.1% | +1.4% | +35.5% | -30.0% | -1.2% | – | |
| – | -2.7% | -3.2% | +19.6% | +10.0% | +9.5% | +5.1% | +91,055.5% | -99.9% | +15.7% | +83,675.4% | -99.9% | – | |
| – | +7.4% | -8.1% | +4.1% | +6.0% | +2.2% | +2.9% | -8.5% | +4.7% | +21.1% | -15.6% | +11.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -92.6% | +9.1% | -50.0% | -83.3% | +600.0% | +28.6% | -33.3% | -66.7% | +200.0% | +0.0% | -33.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | +21.5% | -62.1% | – | – | – | -68.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.